Literature DB >> 479108

Plasmenylethanolamine: growth factor for cholesterol-reducing Eubacterium.

G E Mott, A W Brinkley.   

Abstract

A plasmalogen, plasmenylethanolamine, is required for in vitro growth of strains of Eubacterium which convert cholesterol to coprostanol. Plasmenylethanolamine was isolated from calf brain by selective saponification of lipid fractions separated by thin-layer or column chromatography. Cholesterol-containing thioglycolate broth plus purified plasmenylethanolamine or its 2-lyso derivative supported growth of Eubacterium ATCC 21408 and a cholesterol-reducing Eubacterium isolated from baboon feces. Plasmenylethanolamine obtained from commercial sources also supported growth of these organisms, but none of a number of other pure lipids would support growth. Metabolism of the alkenyl ether group of plasmenylethanolamine occurred during growth.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 479108      PMCID: PMC218019          DOI: 10.1128/jb.139.3.755-760.1979

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  4 in total

1.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

2.  Conversion of cholesterol into coprosterol by bacteria in vitro.

Authors:  A SNOG-KJAER; I PRANGE; H DAM
Journal:  J Gen Microbiol       Date:  1956-04

3.  Biohydrogenation of sterols by Eubacterium ATCC 21,408--Nova species.

Authors:  H J Eyssen; G G Parmentier; F C Compernolle; G De Pauw; M Piessens-Denef
Journal:  Eur J Biochem       Date:  1973-07-16

4.  Cholesterol-reducing bacterium from human feces.

Authors:  M R Sadzikowski; J F Sperry; T D Wilkins
Journal:  Appl Environ Microbiol       Date:  1977-10       Impact factor: 4.792

  4 in total
  6 in total

Review 1.  Conceptualizing the Vertebrate Sterolbiome.

Authors:  Jason M Ridlon
Journal:  Appl Environ Microbiol       Date:  2020-08-03       Impact factor: 4.792

2.  Growth of cholesterol-reducing Eubacterium on cholesterol-brain agar.

Authors:  A W Brinkley; A R Gottesman; G E Mott
Journal:  Appl Environ Microbiol       Date:  1980-12       Impact factor: 4.792

3.  Isolation and characterization of new strains of cholesterol-reducing bacteria from baboons.

Authors:  A W Brinkley; A R Gottesman; G E Mott
Journal:  Appl Environ Microbiol       Date:  1982-01       Impact factor: 4.792

4.  Ingestion of plasmalogen markedly increased plasmalogen levels of blood plasma in rats.

Authors:  Megumi Nishimukai; Takuya Wakisaka; Hiroshi Hara
Journal:  Lipids       Date:  2003-12       Impact factor: 1.880

5.  Biochemical characterization of cholesterol-reducing Eubacterium.

Authors:  G E Mott; A W Brinkley; C L Mersinger
Journal:  Appl Environ Microbiol       Date:  1980-12       Impact factor: 4.792

6.  Cholesterol Metabolism by Uncultured Human Gut Bacteria Influences Host Cholesterol Level.

Authors:  Douglas J Kenny; Damian R Plichta; Dmitry Shungin; Nitzan Koppel; A Brantley Hall; Beverly Fu; Ramachandran S Vasan; Stanley Y Shaw; Hera Vlamakis; Emily P Balskus; Ramnik J Xavier
Journal:  Cell Host Microbe       Date:  2020-06-15       Impact factor: 21.023

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.